This might help if ever OIL get back into gastro.
https://www.ueg.eu/education/docume..._management_of_barretts_esophagus&file=106418
Conclusion
In the restricted context of this evaluation, the CLE-based strategy is not only more effective but also less costly than the standard strategy i.e. corresponding to the definition of a dominant strategy.
- Forums
- ASX - By Stock
- cost effectiveness
This might help if ever OIL get back into gastro....
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OIL (ASX) to my watchlist
(20min delay)
|
|||||
Last
17.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $142.0M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 93 | 16.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.0¢ | 56888 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 72624 | 0.160 |
2 | 29026 | 0.155 |
6 | 81299 | 0.150 |
1 | 5000 | 0.145 |
1 | 50000 | 0.140 |
Price($) | Vol. | No. |
---|---|---|
0.170 | 50000 | 1 |
0.180 | 123689 | 3 |
0.185 | 132650 | 4 |
0.190 | 30000 | 1 |
0.195 | 268571 | 3 |
Last trade - 09.12am 18/11/2024 (20 minute delay) ? |
Featured News
OIL (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online